Eudaemon Technologies

Check out the feature story on Eudaemon Technologies Hydrogel Condom platform on Bench Side Story. “Over 1 million STI's being diagnosed every day and up to 120 million unplanned pregnancies every year result in a $60 billion health burden across the globe”, says Co-Founder and Executive Director of Operations, Dr Simon Cook. According to Executive Chairman and Co-Founder Nick Northcott, the company has made significant progress in the past six months, including completing a pilot clinical trial involving 35 couples and achieving a major milestone. "The completion of this Pilot Clinical Trial is a major milestone and value inflection point for the company. The Pilot Clinical data provides strong signal for safety, efficacy and consumer preference for Eudaemon's Hydrogel Condom platform. We are now poised to move through scaling up our manufacturing, completing a Pivotal Clinical Trial prior to regulatory submission and then entering the market and commercialisation. A very exciting time for Eudaemon Tech as an Australian MedTech manufacturer." https://lnkd.in/gGeJYymv Nick Northcott Robert Gorkin Simon Cook David Shepherd Esther Ong Lam T. Natalie Barber Allison Northcott www.benchsidestory.com

We are thrilled to share an exciting update on our journey towards the development of our next-generation hydrogel condom (Geldom). In the past couple of months our team has diligently been working towards bringing the Geldom into clinical testing and delighted to announce that this significant milestone has been reached with the pilot study underway. We are immensely grateful for the unwavering support and dedication of our team, partners, and funders throughout this journey. Together we are poised to make a meaningful impact in the field of Sexual and Reproductive Health & Wellness. Stay tuned for further updates as we embark on this exciting phase of our development journey. Please do not hesitate to reach out if you want to know more at info@eudaemontech.com. Nick Northcott Robert Gorkin Simon Cook Natalie Barber Esther Ong Allison Northcott Helen Plummer #clinicaltrial #sexualhealth #reproductivehealth #wellness #medicaldevice

I am delighted to announce I have been invited to Chair the AusMedtech 2024 Plenary ‘Lessons from 20 years of collaborations creating meaningful MedTech ventures’. This year, AusMedtech is honouring the journey of remarkable progress in the industry. The session will feature IDE CEO George Sidis and Eudamon Technologies Executive Director Simon Cook as they discuss the organisation's journey and how IDE Group supported Australian medtech innovators as they improve health outcomes worldwide. I invite you to join me for this inspiring session! Early bird tickets are available here before 26 April https://lnkd.in/gAiQwjk8 #AusMedtech2024 #Innovation #HealthTech #ARIAResearch Nick Northcott Gavin Fox-Smith Robert Yearsley

"Building sovereign capability in MedTech manufacturing is front and centre post covid, the challenge is how we do that in a commercially viable way. Developing deep advanced manufacturing, automation and robotics capabilities is a critical part of making this business case." - Nick Northcott, Eudaemon Technologies. Panellist of the How Australia Can Grow a Robust MedTech Manufacturing Capability session at the MTAA MedTech Conference. #MTAA #MedTech #MedTech23

Enjoyed the discussion this morning on a panel for the Medical Technology Association of Australia (MTAA) conference. We discussed how we can grow our local MedTech manufacturing capability and I shared the story of the Eudaemon Technologies journey towards scaled manufacturing and commercialisation - we are only just getting started! Thanks to my fellow panellists Shelley Jackson Bradley Trewin Susie Nilsson and moderator Stuart Anderson. Eudaemon Technologies Chrysalis Advisory